Clinical Trials at UH Minoff Health Center at Chagrin Highlands
As of July 2026, 4 paid clinical trials are recruiting at UH Minoff Health Center at Chagrin Highlands in Orange, Ohio. Active studies at this site cover conditions such as Cancer of the Prostate, Carcinoma, Non-Small-Cell Lung and Carcinoma, Non-Small-Cell Lung (NSCLC). Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
4 clinical trials at UH Minoff Health Center at Chagrin Highlands
·Clear filters·This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Common conditions studied in Orange
- Cancer of the Prostate (1 active study)
- Carcinoma, Non-Small-Cell Lung (1 active study)
- Carcinoma, Non-Small-Cell Lung (NSCLC) (1 active study)
- Cervical Cancer (1 active study)
- Cutaneous Melanoma, Stage II (1 active study)
- Hormone Sensitive Prostate Cancer (1 active study)
Leading research sponsors in Orange
- Pfizer
- GOG Foundation
- Melanoma and Skin Cancer Trials Limited
Frequently asked questions
How many paid clinical trials are currently recruiting in Orange?
There are approximately 6 recruiting clinical trials in Orange, Ohio listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Orange pay participants?
Most recruiting trials in Orange compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Orange?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Orange?
The most common conditions under active study in Orange include Cancer of the Prostate (1), Carcinoma, Non-Small-Cell Lung (1), Carcinoma, Non-Small-Cell Lung (NSCLC) (1), Cervical Cancer (1), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Orange?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Orange on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Orange?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Orange?
Recruiting research sites in Orange include UH Minoff Health Center at Chagrin Highlands, UH Minoff Health Center/Chagrin Highlands- Seidman Cancer Center, University Hospitals Chagrin Highlands Medical Centre, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Orange right now?
The largest active categories in Orange are Cancer & tumors (6). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.